induce any changes in recipient mice. It seemed unlikely that the adoptive transfer of contammanng granulocytes was responsible for the granulocyte abnormahty, because mice injected with mutant spieen cells contaimng >90% granulocytes did not develop an abnormal phenotype tn any cell hneage. However, the expression of IL-2Rß on myeloid cells necessitates cautious Interpretation of these data; we cannot yet exclude the possibihty that receptor deficiency may play some direct role m the observed myeloid disorder.
induce any changes in recipient mice. It seemed unlikely that the adoptive transfer of contammanng granulocytes was responsible for the granulocyte abnormahty, because mice injected with mutant spieen cells contaimng >90% granulocytes did not develop an abnormal phenotype tn any cell hneage. However, the expression of IL-2Rß on myeloid cells necessitates cautious Interpretation of these data; we cannot yet exclude the possibihty that receptor deficiency may play some direct role m the observed myeloid disorder.
Taken together, our results suggest that IL-2Rß, in addition to lts known role as a mediator of activation Signals for Τ cell prohferation, is also a central component of the regulatory System in Τ cells. It appears that a complete lack of signahng through the IL-2Rß chain can result in deregulation of these lymphocytes and consequent loss of homeostasis and autoimmumty.
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In the 1970s, human bone marrow transplantation (BMT) became available as a therapy for severe aplastic anemia, leukemia, and immune defictency disease (I). The long-terrn results of allogeneic BMT have greatly improved for a variety of reasons, including the participation of HLAmatched siblings as marrow donors, advancements in pretransplant chemoradiotherapy, the prophylactic use of potent 1m-munosuppressive drugs, and better antibiot-ICS and Isolation procedures. Nonetheless, the selection of major histocompatibility complex (MHC)-identical donors and recipients does not guarantee avoidance of GVHD, nor does it ensure disease-free survival, even when the donor and the recipient are closely related (2). Up to 80% of cases of GVHD result from allogeneic BMT between unrelated HLA-matched adults (3, 4) . Dispanties m mmor histocompatibility antigens (mHags) between the donor and the reciptent constitute a sigmficant nsk for graft failure or GVHD. These conditions necessitate lifelong pharmacological lmmunosuppression of organ and BMT recipients (3, 5, 6) Cytotoxrc Τ lymphocytes (CTLs) that are specific for host mHags have been detected in patients who develop GVHD after BMT from donors who are genotypically HLA-identical (7). Immunogenetic analyses with CTL clones have identified five non-sex-hnked mHags, destgnated HA-1 through -5, that are recognized in a classical MHC-restricted fashion (8) and are produets of Single genes that segregate in a Mendehan fashion (9) . In a prospective study, mismatching of these mHags significantly correlated with GVHD (6) . These mHags show defmed phenotype frequencies (8) and tissue distnbution patterns (10) . HA-1 and HA-2 are uniquely expressed on hematopoietic-denved cells, including leukemic cells (]]), whereas HA-3 and HA-4 are present on other cell types as well (10) . tertzed at the molecular level H-3, which depends on allehc forms of ß r microglobulm associated with class I MHC molecules (12) , and the nutochondnally encoded, maternally transmitted antigen presented by Hmt molecules (13) . However, although some conventional munne and human mHags have beert shown to be peptides presented by MHC molecules (14, 15) , the exact amino acid sequence of these peptides and the identification of the proteins from which they ongmate have not been reported Here, we report the identification by tandem mass spectrometry of a peptide that represents the HLA-A2.1-restncted HA-2 epitope.
To isolate HA-2, we used affinity chromatography to punfy HLA-A2.1 molecules from Epstetn-Barr virus transformed Β lymphocytes (EBV-BLCLs) expressing HA-2 The HLA-A2.1-bound peptides were ISOlated by acid treatment and 10-kD filtration (13) These low molecular mass molecules were fractionated by reversed-phase htgh-performance liquid chromatography (HPLC), and individual fractions were analyzed for HA-2-sensitizmg activity by incubation with the HA-2-negative, HLA-A2.1-positive lymphoblastoid cell line T2 in a 51 Cr release assay One fraction (fraction 33) sensitized T2 for lysis by the HA-2-specific CTL clone 5H17 (16) (Fig 1A) .
When fraction 33 was rechromatographed with a shallower gradient, HA-2-sensitizmg activity was observed in fractions 37 and 38 ( Fig 1B) However, as assessed by microcapillary HPLC-electrospray lonization tandem mass spectrometry, the latter fractions still contained more than 100 different HLA-A2-binding peptides (17) To determine which of the peptides was responsible for the HA-2-sensitizing activity, we rechromatographed fraction 37 by microcapillary HPLC The effluent was spht with an on-line sphtter (18) and was directed simultaneously mto the mass spectrometer and into a 96-well microtiter plate for a subsequent 5I Cr release assay In this way, mass spectrometry data on individual pepf ides could be correlated with epitope recon- 51 Cr release assay Second-dimen sion fraction 37 (from Fig  1B) was separated with an on-line microcapillary effluent sphtter (79) AC 18 microcapillary HPLC column (100 |im by 25 cm) was butt-connected with a zero dead volume union (Valco, Phoenix, Arizona) to two capillanes of different lengths and intenor diameters (25 and 40 μΓη, Polymicro Technologies, Houston, Tex as), and peptides were eluted with a 34-min gradient of 0 to 60% acetonrtnle The 25 μπι capillary deposited one-sixth of fhe matenal into microtiter plate wells (10-s fractions) containing 150 μΙ of RPMI 1640 with 10% human serum culture medium for CTL analysis Α 50-μΙ portion of the contents of each well was incubated with 2500 T2 cells in a final volume of 100 μΙ for 1 hour at 37°C, and 50 μΙ of CTL was added to yield an effector target ratio of 40 1 The 40-μιη capillary directed the remaining flve-sixths of the matenal into the electrospray lonization source, and the mass spectra of the peptides deposited into each well were recorded on a tnple-quadrupole mass spectrometer (Finmgan ΜΑΤ, San Jose, California) (A) Epitope reconstituting activity is measured as percent specific release stitution activity Figure 2A shows a Single peak of HA-2-sensitizmg activity in wells 50 to 53 Of the many peptides present in these wells (Fig 2B) , the relative ιοη abundance profile of five [with mass-to-charge ratios (m/z) of 651, 869, 965, 979, and 1000] matched the activity profile of the HA-2-specific CTL-sensitizing activity (Fig 2A) Collision-activated dissociation (CAD) analysis performed for the species with mjz of 979 revealed the existence of two different peptides, YXGEVXVSV and SXDF-GTXQV (19) (Fig 3, Α and B) The X represents L or I, which cannot be distmguished by mass spectrometry under these conditions We next made synthetic peptide mixtures with an equimolar mixture of L and I in place of X and assayed them for HA 2-specific CTL-sensitizing activity Only mcubation with peptide mixture YX-GEVXVSV resulted in lysis of T2 (17, 20) To identify the naturally processed peptide epitope, we synthesized four peptides with I or L at positions 2 and 6 Microcapdlary HPLC coelution studies revealed that three of these synthetic peptides (YIGEV-LVSV, YLGEVLVSV, and YLGEVIVSV) coeluted with the naturally processed peptide, whereas peptide Y1GEVIVSV did not (i 7) These three peptides could not be distinguished from one another or from the naturally processed peptide under several different HPLC elution conditions All three peptides sensitized the T2 cell hne for lysis by ebne 5H17 (Fig 4A) Peptide YIGEV-LVSV sensitized targets for half-maximal lysis at a concentration of 40 pM, whereas the sensitizing concentrations for peptides YL-GEVLVSV and YLGEVIVSV were substantially higher (1 5 and 2 25 nM, respectively) These concentrations were withm the ränge of 10 pM to 50 nM established for other naturally processed epitopes (18, 21) Panel analysis mdicates that ebne 5H13 IS an ιη-dependently derived CTL that also recogmzes HA-2 but differs shghtly from ebne 5H17 in lts fine specificity of antigen recognition (8, 22) Cbne 5H13 also recognized all three peptide vanants (Fig 4B) Although the concentration of peptides necessary to give haK-maximal epitope reconstitution was 5 to 10 times higher than for ebne 5H17, peptide YIGEVLVSV still sensitized at one-hundredth the concentration of the other two Thus, despite their fme specificity differences, both HA-2-specific CTL ebnes recognized the same peptide epitope Bmdmg studies with these three peptides showed that peptide YIGEVLVSV also had the highest bmdmg affmity for HLA A2 1 The concentration of YIGEVLVSV that inhibited the binding of the lodmated Standard peptide to punfied HLA A2 1 by 50% (IC 50 ) was 6 7 nM, whereas the IC 50 values for YLGEVLVSV and YLGEVIVSV were 17 and 27 nM, respectively ( values place these peptides among the Jhighest-affinity naturally processed peptides that have been identified to date (23) However, although there is less than a fourfold difference in bindmg äffmities among these three peptides, peptide YIGEVLVSV sensitizes target cells for recognition by ebnes 5H17 and 5H13 at one-ftftieth to one-hundredth the concentration of the other two This f mdmg mdicates that peptide YIGEVLVSV is recognized with the highest affmity by the Τ cell reeeptors of both of these CTL ebnes, and that it is the actual HA-2 epitope
To determine the quantity of HA-2 peptide present on EBV-BLCLs, we compared a positive HPLC fraction with a known SCIENCE · VOL 268 · 9 JUNE 1995 amount of synthetic peptide on the mass spectrometer Assummg an overall punfteation yield of 12% (18), we estimated that 260 HA-2 peptide-HLA-A2 1 complexes were expressed per cell This number is similar to values determined for other sequenced Τ cell epitopes (18, 21), and it mdicates that HA-2 is moderately abundant compared with other naturally processed peptides (18, 24) Α search of DNA and protein sequence databases identified six distmct coding sequences that match peptide YIGEVLVSV at eight of nine residues, and an additional seven that match at seven of nine residues All of these sequences are derived from non- CTL cione 5H17 and (B) CTL ebne 5H13 Peptides were ineubated with 2500 T2 cells in a total volume of 50 μΙ of HBSS containing 50 mM Hepes for 30 min at 37°C In (A), 100 μΙ of ebne 5H17 was added to yield an effector target ratio of 26.1, in (B), 100 μΙ of ebne 5H13 was added to yield an effector target ratio of 7 1. Background lysis of T2 in the absence of peptide was 12% by ebne 5H17 in (A) and 1% by ebne 5H13 in (B). Spontaneous release of T2 ineubated with peptide never exceeded 5% Lysis of HA-2-posrtive EBV BLCLs was 86% by ebne 5H17 in (A) and 93% by cbne5H13in(B).
110-, filamentous class I myosms, a large family of proteins that are uwolved in cell locomonon and organelle transport (25, 26) . Most mismatches to the HA-2 sequence oecurred at peptide position 4. Nonetheless, at least two class I myosm sequences contain a glutamic acid at this position. The dosest known human sequence corresponds to resldues 51 to 59 from unconventional myosm IC (YIGSVLISV), which is also the only completely sequenced class I myosm gene (27). However, although different cell types appear to express multiple class I myosms simultaneously, tissue-restneted expression of class I myosms has also been reported (26, 28) . Because the total number of famlly members is still not known, the HA-2 peptide epitope IS most hkely denved from an as yet uncharactenzed human class I myosm protein.
Virtually all of the known class I myosin sequences, regardless of their species of ongm, show identity at six or more of the rane positions withm the sequence that corresponds to the HA-2 peptide, and these sequences also contam an lsoleucme at position 2 and a valine at position 9. These latter residues represent the most important elements of the HLA-A2.1-binding motif (23, 29) . Thus, the basis for differential expression of the mHag HA-2 withm the human population may be allelic polymorphism that results in presentation of homologous but nomdentical peptides from this region by HLA-A2.1 molecules, or in the 0 001 0.01 01 1
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100 failure to present a peptide that has lost one of the motif residues. However, the large amount of HA-2-related sequence conservation among different class I myosins from the same species also suggests that several peptides related to HA-2 may be expressed m association with HLA-A2.1 in a Single individual and may be cross-reactively recognized by HA-2-specific Τ cells. Indeed, the human class IC myosin-denved peptide YIGSVLISV was able to sensitize T2 cells for lysis by ebnes 5H17 and 5H13 and could induce 50% lysis at concentrations of 5 to 50 nM (17). Because these peptides could also exert a profound tolerogenic effect on the HA-2-specific Τ cell repertoire, an alternative hypothesis is that a polymorphism in the class I antigen processmg System results in a failure to express all or many members of this set of peptides in HA-2-negative mdividuals. Finally, because HA-2 is only presented by hematopoietic cells, either the expression of lts unknown class I myosin source protem is tissue-specific or HA-2 is only presented as a consequence of tissuespecific processmg. Until now, Information on mHags has been scarce. Although the physiological function of mHags is still unknown, their pivotal role in organ transplantation in general, and in BMT in particular, is undeniable. The availability of the mHag peptide sequence may allow in vivo modtfication of GVHD-related Τ cell responses. Because the mHag HA-2 is expressed on cells of the father She developed severe acute GVHD (grade III) followed by extensive chronic GVHD The HA 2-specific CTL clone was generated from post BMT penpheral blood lymphocytes accordmg to the pro tocol descnbed earlier [E Goulmy in Transplantation Reviews, Vol 2, J Morris and Ν L Tilney Eds The cell cycle of Prochlorococcus, a prokaryote that accounts for a sizable fraction of the photosynthetic biomass in the eastern equatorial Pacific, progressed in phase with the daily light cycle. DNA replication occurred in the afternoon and cell division occurred at night. Growth rates were maximal (about one doubling per day) at 30 meters and decreased toward the surface and the bottom of the ocean. Estimated Prochlorococcus production vaned between 174 and 498 milligrams of carbon per square meter per day and accounted for 5 to 19 percent of total gross primary production at the equator. Because Prochlorococcus multiphes dose to its maximum possible rate, it is probably not severely nutnent-limited in this region of the oceans.
Assessment of microbial population growth rate ir> aquatic Systems is difficult because ubiquitous grazers remove cells as quickly as they are produced If the cell cycle of a populatton is in phase with the datly light cycle, cell division rates can be estimated from changes in the fractions of cells in each cell cycle stage (/) This approach does not require sample mcubation, whiüi is always a potential source of artifacts We used cell cycle fractions to tnvestigate division rates of the phytoplanktonic prokaryote Prochlorococcus (2) in the equatorial Pacific at 140°W ( 
1480
Prochlorococcus decreased in abundance but was present down to 150 m (1 April, Fig. 1 ) Flow cytometne DNA histograms displayed a Single peak composed of cells in the G, phase of the cell cycle (3) dunng the late hours of night and in the early morning ( 
